SNL Sketch Exposes the Absurd Disconnect of Online Realities
A recent SNL sketch skillfully highlights how personalized algorithms can distort our perceptions and connections in real life.
October 04, 2026
Entertainment
Entertainment news, movies, and celebrities
Anticipating the Nobel Prize: Insights from Mary-Claire King on Recognition and Legacy
Mary-Claire King shares her experience and thoughts on the impact of her work amidst the suspense of the Nobel Prize anticipation.
October 02, 2026
Challenges Persist in Retaining Young People in Opioid Addiction Treatment
Despite increased access to addiction medications for youth, retention remains alarmingly low, raising urgent concerns among healthcare professionals.
October 02, 2026
Lilly's Direct-to-Consumer Strategy Avoids Australian Pharmacies
Lilly adopts a direct-to-consumer model in Australia, bypassing traditional pharmacies to streamline access to its products.
October 02, 2026
NIH Faces Criticism Over Grant Distribution and Delays in Research Funding
NIH's fiscal year 2026 grant distribution raises concerns among researchers due to delays and a decline in project funding.
October 02, 2026
Pharmacy Perspectives: Bridging the Gap Between Orphan Drugs and Patient Needs
Pharmacists face challenges in the orphan drug landscape, as policy gaps hinder personalized care for patients with specific conditions.
October 02, 2026
Medicare Advantage Plans Face Increased Costs and Reduced Benefits in 2027
Enrollees in Medicare Advantage plans for 2027 need to prepare for higher out-of-pocket expenses and fewer benefits during the upcoming enrollment period.
October 01, 2026
New Perspectives on Women's Health: A Closer Look at Menopause and Pain
A recent special issue of Science highlights the need for more research in women's health, particularly on menopause, pain mechanisms, and beyond.
October 01, 2026
China's Biotech Growth: Insights from an On-the-Ground Perspective
Explore the vibrant pulse of China's biotech sector, offering firsthand insights into its rapid advancements and ongoing challenges.
October 01, 2026
Invivyd's Monoclonal Antibody Shows Promising Results Against Covid-19
Invivyd's Phase 3 study shows its monoclonal antibody, VYD2311, offers better tolerability than the Pfizer vaccine, suggesting a potential alternative for Covid-19 protection.
October 01, 2026
Huntington's Advocate Responds to UniQure's Latest Gene Therapy Results
Despite a decline in effectiveness, Huntington's patient Lauren Holder remains optimistic about UniQure's gene therapy for slowing disease progression.
October 01, 2026
Understanding the Rise of GLP-1 Prescriptions for Children with Obesity
A significant surge in GLP-1 prescriptions for children highlights a growing response to childhood obesity and its medical implications.
October 01, 2026
China's Biotech Sector Champions Efficiency Amid Global Competition
Biotech leaders in Shanghai tout rapid drug development in China, positioning themselves as a competitive force against Western markets.
October 01, 2026
Can Eric Cantor Revitalize Pharma's Image Among Voters?
Eric Cantor seeks to reshape the pharmaceutical industry's image and policies to align with voter concerns, revisiting past strategies aimed at broader public appeal.
October 01, 2026
Study Reveals Lingering Health Risks from Toxic Metals Post-Wildfires in Maui
Research highlights the long-term respiratory risks posed by toxic metals from the 2023 Maui wildfires, persisting even after the flames have subsided.
September 28, 2026
The Dire Future of Employer-Sponsored Health Insurance
The outlook for employer-sponsored health insurance is grim, with experts predicting even higher costs in 2027, as recent trends worsen the situation.
September 28, 2026
AbbVie Gains FDA Approval for New Parkinson's Treatment Pill
The FDA has approved AbbVie's new oral medication for Parkinson's disease, marking a significant advancement in treatment options for patients.
September 28, 2026
Novo Nordisk's GLP-1s: Bridging Medical and Lifestyle Drug Categories
Novo Nordisk blurs the line between medications and lifestyle enhancements with its GLP-1s, sparking debate over their true classification.
September 28, 2026
Eleven Manufacturers Secure Generic Licensing for Roche's Influenza Treatment
A U.N.-backed agency has partnered with 11 manufacturers to produce generic versions of Roche's flu treatment Xofluza, enhancing access in low-income nations.
September 25, 2026
Understanding the Shift in Biotech: Insights from China and FDA Nominee Heidi Overton
Explore the implications of rising Chinese biotech development and the potential impact of FDA nominee Heidi Overton on U.S. drug regulation.
September 24, 2026